28 participants
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2024-11-20
- Completion:
- 2027-12-31
Conditions
- Triple Negative Breast Cancer
Interventions
- BIOLOGICAL
No Results Yet